Fabio Conforti

机构：Humanitas University, Humanitas Gavazzeni · ORCID：0000-0002-6233-0502

发表论文 176 篇 · 总被引 4090 次 · h-index 27

代表论文

• Sex hormones, the anticancer immune response, and therapeutic opportunities (2025 · Cancer Cell · 被引 42)
• Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis (2025 · Annals of Oncology · 被引 39)
• Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses (2025 · Cancers · 被引 24)
• Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective study (2025 · ESMO Open · 被引 19)
• Aprepitant use during chemotherapy and association with survival in women with early breast cancer (2025 · JNCI Journal of the National Cancer Institute · 被引 12)
• Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025 · The Lancet Oncology · 被引 7)